Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer
- Autores
- Duca, Rocío Belén; Farré, Paula Lucía; Graña, Karen Daniela; Massillo, Cintia Lorena; Garcia, Nicolas; Dimase, Federico; Gandini, Norberto Ariel; Dalton, Guillermo Nicolás; de Siervi, Adriana
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- .Prostate cancer (PCa) is the most common type of cancer and the third cause of death by cancer in Argentinian men. miRNAs are small non-coding RNA molecules that regulate gene expression. miRNAs can be secreted by tumor cells and circulate in the bloodstream. Our aim was to identify circulating miRNAs as candidate biomarkers for the diagnosis of PCa. GeneChip® miRNA 4.0 Arrays (Affymetrix) were hybridized with circulating RNA obtained from serum of PCa patients or healthy donors. Diagnosed PCa patients, free of treatment, were divided into subcategories according to Gleason grade. After data normalization, we identified a list of miRNAs (miR-4668-5p, miR 2277-5p, miR-3613-3p, miR-101-3p, miR-320e-5p, miR-6750- 5p, miR-548x-3p, miR-320a, miR-4532, miR-21-5p) that were increased in PCa patients serum compared to healthy donors. To validate these results, NSG mice were inoculated s.c. with PC3 or 22Rv1 PCa cell lines. After tumor growth, mice with tumors and a non-tumor mice group (control) were sacrificed. Blood and tumor samples were collected for RNA isolation. miRNA expression levels were assessed by stem-loop RT-qPCR. miR-4668-5p, miR 2277-5p, miR-3613-3p and miR-21-5p were significantly increased in the circulation of mice inoculated with PC3 cells compared to control. Also, miR-101-3p and miR-3613-3p were significantly upregulated in the plasma of mice that were inoculated with 22Rv1 compared to control. miR-2277-5p was not detected in the plasma of 22Rv1 injected mice. Interestingly, miR-101-3p was increased in circulation of 22Rv1 compared to PC3 injected mice, while miR-4668-5p was increased in plasma of PC3 compared to 22Rv1 injected mice. Additionally, miR-101- 3p was upregulated in 22Rv1 compared to PC3 xenografts. In summary, our work defines novel candidate biomarkers for PCa diagnosis based on circulating miRNAs from human serum samples. These biomarkers were also detected in xenografts and plasma from mice.
Fil: Duca, Rocío Belén. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Farré, Paula Lucía. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Graña, Karen Daniela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Massillo, Cintia Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Garcia, Nicolas. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; Argentina
Fil: Dimase, Federico. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; Argentina
Fil: Gandini, Norberto Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina
Fil: Dalton, Guillermo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: de Siervi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Reunión Anual de Sociedades de Biociencia
Mar del Plata
Argentina
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
The Histochemical Society - Materia
-
PROSTATE
CANCER
BIOMARKER
miRNAs - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/158770
Ver los metadatos del registro completo
id |
CONICETDig_4d5a02a52d8a9cfcfa83781ded38d185 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/158770 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancerDuca, Rocío BelénFarré, Paula LucíaGraña, Karen DanielaMassillo, Cintia LorenaGarcia, NicolasDimase, FedericoGandini, Norberto ArielDalton, Guillermo Nicolásde Siervi, AdrianaPROSTATECANCERBIOMARKERmiRNAshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3.Prostate cancer (PCa) is the most common type of cancer and the third cause of death by cancer in Argentinian men. miRNAs are small non-coding RNA molecules that regulate gene expression. miRNAs can be secreted by tumor cells and circulate in the bloodstream. Our aim was to identify circulating miRNAs as candidate biomarkers for the diagnosis of PCa. GeneChip® miRNA 4.0 Arrays (Affymetrix) were hybridized with circulating RNA obtained from serum of PCa patients or healthy donors. Diagnosed PCa patients, free of treatment, were divided into subcategories according to Gleason grade. After data normalization, we identified a list of miRNAs (miR-4668-5p, miR 2277-5p, miR-3613-3p, miR-101-3p, miR-320e-5p, miR-6750- 5p, miR-548x-3p, miR-320a, miR-4532, miR-21-5p) that were increased in PCa patients serum compared to healthy donors. To validate these results, NSG mice were inoculated s.c. with PC3 or 22Rv1 PCa cell lines. After tumor growth, mice with tumors and a non-tumor mice group (control) were sacrificed. Blood and tumor samples were collected for RNA isolation. miRNA expression levels were assessed by stem-loop RT-qPCR. miR-4668-5p, miR 2277-5p, miR-3613-3p and miR-21-5p were significantly increased in the circulation of mice inoculated with PC3 cells compared to control. Also, miR-101-3p and miR-3613-3p were significantly upregulated in the plasma of mice that were inoculated with 22Rv1 compared to control. miR-2277-5p was not detected in the plasma of 22Rv1 injected mice. Interestingly, miR-101-3p was increased in circulation of 22Rv1 compared to PC3 injected mice, while miR-4668-5p was increased in plasma of PC3 compared to 22Rv1 injected mice. Additionally, miR-101- 3p was upregulated in 22Rv1 compared to PC3 xenografts. In summary, our work defines novel candidate biomarkers for PCa diagnosis based on circulating miRNAs from human serum samples. These biomarkers were also detected in xenografts and plasma from mice.Fil: Duca, Rocío Belén. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Farré, Paula Lucía. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Graña, Karen Daniela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Massillo, Cintia Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Garcia, Nicolas. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; ArgentinaFil: Dimase, Federico. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; ArgentinaFil: Gandini, Norberto Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; ArgentinaFil: Dalton, Guillermo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: de Siervi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaReunión Anual de Sociedades de BiocienciaMar del PlataArgentinaSociedad Argentina de Investigación ClínicaAsociación Argentina de Farmacología ExperimentalSociedad Argentina de BiologíaSociedad Argentina de ProtozoologíaAsociación Argentina de NanomedicinasAsociación Argentina de Ciencia y Tecnología de Animales de LaboratorioThe Histochemical SocietyFundación Revista Medicina2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/158770Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer; Reunión Anual de Sociedades de Biociencia; Mar del Plata; Argentina; 2019; 147-1470025-76801669-9106CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.saic.org.ar/revista-medicinaNacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:59:02Zoai:ri.conicet.gov.ar:11336/158770instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:59:03.168CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
title |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
spellingShingle |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer Duca, Rocío Belén PROSTATE CANCER BIOMARKER miRNAs |
title_short |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
title_full |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
title_fullStr |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
title_full_unstemmed |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
title_sort |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer |
dc.creator.none.fl_str_mv |
Duca, Rocío Belén Farré, Paula Lucía Graña, Karen Daniela Massillo, Cintia Lorena Garcia, Nicolas Dimase, Federico Gandini, Norberto Ariel Dalton, Guillermo Nicolás de Siervi, Adriana |
author |
Duca, Rocío Belén |
author_facet |
Duca, Rocío Belén Farré, Paula Lucía Graña, Karen Daniela Massillo, Cintia Lorena Garcia, Nicolas Dimase, Federico Gandini, Norberto Ariel Dalton, Guillermo Nicolás de Siervi, Adriana |
author_role |
author |
author2 |
Farré, Paula Lucía Graña, Karen Daniela Massillo, Cintia Lorena Garcia, Nicolas Dimase, Federico Gandini, Norberto Ariel Dalton, Guillermo Nicolás de Siervi, Adriana |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
PROSTATE CANCER BIOMARKER miRNAs |
topic |
PROSTATE CANCER BIOMARKER miRNAs |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
.Prostate cancer (PCa) is the most common type of cancer and the third cause of death by cancer in Argentinian men. miRNAs are small non-coding RNA molecules that regulate gene expression. miRNAs can be secreted by tumor cells and circulate in the bloodstream. Our aim was to identify circulating miRNAs as candidate biomarkers for the diagnosis of PCa. GeneChip® miRNA 4.0 Arrays (Affymetrix) were hybridized with circulating RNA obtained from serum of PCa patients or healthy donors. Diagnosed PCa patients, free of treatment, were divided into subcategories according to Gleason grade. After data normalization, we identified a list of miRNAs (miR-4668-5p, miR 2277-5p, miR-3613-3p, miR-101-3p, miR-320e-5p, miR-6750- 5p, miR-548x-3p, miR-320a, miR-4532, miR-21-5p) that were increased in PCa patients serum compared to healthy donors. To validate these results, NSG mice were inoculated s.c. with PC3 or 22Rv1 PCa cell lines. After tumor growth, mice with tumors and a non-tumor mice group (control) were sacrificed. Blood and tumor samples were collected for RNA isolation. miRNA expression levels were assessed by stem-loop RT-qPCR. miR-4668-5p, miR 2277-5p, miR-3613-3p and miR-21-5p were significantly increased in the circulation of mice inoculated with PC3 cells compared to control. Also, miR-101-3p and miR-3613-3p were significantly upregulated in the plasma of mice that were inoculated with 22Rv1 compared to control. miR-2277-5p was not detected in the plasma of 22Rv1 injected mice. Interestingly, miR-101-3p was increased in circulation of 22Rv1 compared to PC3 injected mice, while miR-4668-5p was increased in plasma of PC3 compared to 22Rv1 injected mice. Additionally, miR-101- 3p was upregulated in 22Rv1 compared to PC3 xenografts. In summary, our work defines novel candidate biomarkers for PCa diagnosis based on circulating miRNAs from human serum samples. These biomarkers were also detected in xenografts and plasma from mice. Fil: Duca, Rocío Belén. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Farré, Paula Lucía. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Graña, Karen Daniela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Massillo, Cintia Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Garcia, Nicolas. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; Argentina Fil: Dimase, Federico. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; Argentina Fil: Gandini, Norberto Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina Fil: Dalton, Guillermo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: de Siervi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Reunión Anual de Sociedades de Biociencia Mar del Plata Argentina Sociedad Argentina de Investigación Clínica Asociación Argentina de Farmacología Experimental Sociedad Argentina de Biología Sociedad Argentina de Protozoología Asociación Argentina de Nanomedicinas Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio The Histochemical Society |
description |
.Prostate cancer (PCa) is the most common type of cancer and the third cause of death by cancer in Argentinian men. miRNAs are small non-coding RNA molecules that regulate gene expression. miRNAs can be secreted by tumor cells and circulate in the bloodstream. Our aim was to identify circulating miRNAs as candidate biomarkers for the diagnosis of PCa. GeneChip® miRNA 4.0 Arrays (Affymetrix) were hybridized with circulating RNA obtained from serum of PCa patients or healthy donors. Diagnosed PCa patients, free of treatment, were divided into subcategories according to Gleason grade. After data normalization, we identified a list of miRNAs (miR-4668-5p, miR 2277-5p, miR-3613-3p, miR-101-3p, miR-320e-5p, miR-6750- 5p, miR-548x-3p, miR-320a, miR-4532, miR-21-5p) that were increased in PCa patients serum compared to healthy donors. To validate these results, NSG mice were inoculated s.c. with PC3 or 22Rv1 PCa cell lines. After tumor growth, mice with tumors and a non-tumor mice group (control) were sacrificed. Blood and tumor samples were collected for RNA isolation. miRNA expression levels were assessed by stem-loop RT-qPCR. miR-4668-5p, miR 2277-5p, miR-3613-3p and miR-21-5p were significantly increased in the circulation of mice inoculated with PC3 cells compared to control. Also, miR-101-3p and miR-3613-3p were significantly upregulated in the plasma of mice that were inoculated with 22Rv1 compared to control. miR-2277-5p was not detected in the plasma of 22Rv1 injected mice. Interestingly, miR-101-3p was increased in circulation of 22Rv1 compared to PC3 injected mice, while miR-4668-5p was increased in plasma of PC3 compared to 22Rv1 injected mice. Additionally, miR-101- 3p was upregulated in 22Rv1 compared to PC3 xenografts. In summary, our work defines novel candidate biomarkers for PCa diagnosis based on circulating miRNAs from human serum samples. These biomarkers were also detected in xenografts and plasma from mice. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Reunión Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/158770 Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer; Reunión Anual de Sociedades de Biociencia; Mar del Plata; Argentina; 2019; 147-147 0025-7680 1669-9106 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/158770 |
identifier_str_mv |
Circulating miRNAs as potential biomarkers for the early diagnosis of prostate cancer; Reunión Anual de Sociedades de Biociencia; Mar del Plata; Argentina; 2019; 147-147 0025-7680 1669-9106 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.saic.org.ar/revista-medicina |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.coverage.none.fl_str_mv |
Nacional |
dc.publisher.none.fl_str_mv |
Fundación Revista Medicina |
publisher.none.fl_str_mv |
Fundación Revista Medicina |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269558046457856 |
score |
13.13397 |